Stitch Fix, Discovery, Atlassian & more


Check out the businesses making headlines after the bell on Tuesday:

Atlassian — Shares of the Australian software program firm ticked up 1% on revised income steerage for the fiscal third quarter. Atlassian now expects income between $566 million and $572 million. Analysts polled by FactSet beforehand predicted income of $487.2 million for the corporate’s third quarter. The new forecast can also be above Atlassian’s earlier income steerage for the quarter.

Stitch Fix — Shares of the non-public styling service slid 3.2% after the corporate introduced that founder and CEO Katrina Lake will turn out to be the chief chairperson and Elizabeth Spaulding will take over as CEO, efficient Aug. 1.

Endo International — The pharmaceutical firm’s shares ticked up barely after the corporate introduced that promising part 3 knowledge on a cellulite therapy was revealed within the official journal of the American Society of Dermatologic Surgery. The knowledge demonstrated that the therapy offers a clinically significant enchancment within the look of reasonable to extreme cellulite within the buttocks of grownup girls in comparison with placebo. 

Amicus Therapeutics — The biopharmaceuticals firm’s shares rose 3% after analysts at Cantor Fitzgerald upgraded the inventory to obese from impartial, citing the corporate’s promising gene remedy outcomes.

Discovery — Discovery’s Class A and Class C shares dropped 3.8% and 5.1%, respectively, after after CNBC’s David Faber reported that Credit Suisse continues to unload positions in the media company as a result of the blow up of Archegos Capital Management. Citing merchants, Credit Suisse bought 19 million of the media firm’s Class A shares and 22 million in Class C inventory.